Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,177,000 | 3,140,000 | 2,890,000 | 3,523,000 | 3,606,000 |
| Marketable Securities | 3,506,000 | 3,364,000 | 4,085,000 | 4,154,000 | 3,555,000 |
| Inventories | 5,480,000 | 5,512,000 | 5,355,000 | 5,146,000 | 4,659,000 |
| Other current assets | 9,077,000 | 7,332,000 | 7,389,000 | 7,603,000 | 8,429,000 |
| TOTAL | $21,240,000 | $19,348,000 | $19,719,000 | $20,769,000 | $20,249,000 |
| Non-Current Assets | |||||
| PPE Net | 9,454,000 | 9,315,000 | 9,414,000 | 9,620,000 | 9,650,000 |
| Intangibles | 22,268,000 | 22,247,000 | 21,017,000 | 21,364,000 | 22,784,000 |
| Other Non-Current Assets | 7,900,000 | 8,551,000 | 8,446,000 | 8,393,000 | 7,630,000 |
| TOTAL | $39,622,000 | $40,113,000 | $38,877,000 | $39,377,000 | $40,064,000 |
| Total Assets | $60,862,000 | $59,461,000 | $58,596,000 | $60,146,000 | $60,313,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 3,785,000 | N/A |
| Accounts payable and accrued liabilities | 15,582,000 | 13,951,000 | 14,268,000 | 3,866,000 | 16,115,000 |
| Other current liabilities | 1,024,000 | 947,000 | 962,000 | 1,289,000 | 967,000 |
| TOTAL | $22,390,000 | $22,108,000 | $20,696,000 | $22,810,000 | $20,953,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 16,194,000 | N/A |
| Other Non-Current Liabilities | 25,965,000 | 25,226,000 | 26,806,000 | 10,335,000 | 30,716,000 |
| TOTAL | $25,853,000 | $25,194,000 | $26,588,000 | $27,240,000 | $30,644,000 |
| Total Liabilities | $48,243,000 | $47,302,000 | $47,284,000 | $50,050,000 | $51,597,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,348,000 | 1,348,000 | 1,348,000 | 1,347,000 | 1,347,000 |
| Retained earnings | 7,017,000 | 6,418,000 | 5,655,000 | 4,363,000 | 2,592,000 |
| Other shareholders' equity | 1,318,000 | 1,475,000 | 1,368,000 | 1,448,000 | 1,773,000 |
| TOTAL | $13,133,000 | $12,691,000 | $11,820,000 | $10,598,000 | $9,152,000 |
| Total Liabilities And Equity | $61,376,000 | $59,993,000 | $59,104,000 | $60,648,000 | $60,749,000 |